Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers Publication Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers A semi-mechanistic population PK model characterizes sorfequiline and its active M3 metabolite to support DDI…Certara2026 年 9 月 18 日
Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy Poster Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy Pharmacometric modeling of givinostat in pediatric DMD supported a simplified 4-band weight-based dosing regimen without…Certara2026 年 9 月 14 日
Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions Blog Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions Simple allometric scaling stops at clearance and volume. See how Dedrick plots and the Wajima…Danielle Pillsbury2026 年 9 月 11 日
From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud Webinar From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud Arjen Bos2026 年 9 月 3 日
From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling On-Demand Webinar From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling Describe pharmacometric models in natural language and let AI write ready-to-run NLME code. See the…Arjen Bos2026 年 9 月 1 日
An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI Live Events An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI Certara2026 年 9 月 1 日
A glimpse into the future of model-informed drug discovery and development Publication A glimpse into the future of model-informed drug discovery and development Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…Certara2026 年 8 月 28 日
Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology Publication Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…Certara2026 年 8 月 28 日
The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose Webinar The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose Danielle Pillsbury2026 年 8 月 28 日
See an AI assistant run a PK analysis Video See an AI assistant run a PK analysis Watch an AI assistant run a full population PK analysis using the NLME MCP Server,…Certara2026 年 8 月 28 日